Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
National Institutes of Health · Opportunity PAR-25-362
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities
- Native American tribal organizations (other)
- Nonprofits with 501(c)(3), other than higher education
- Nonprofits without 501(c)(3)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
About this opportunity
The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART).This initiative aims to understand intricate mechanisms of immune cells at the maternal-fetal interface, T and B cell development and maturation in offspring, and local immune responses and the role of systemic immunity.
Award history — this exact opportunity
NIH RePORTER lists 2 funded awards under PAR-25-362 across 2 organizations.
Total award obligations, not per-year amounts.
Recent awardees include: YALE UNIVERSITY, OREGON HEALTH & SCIENCE UNIVERSITY.
Source: NIH RePORTER, matched on the exact opportunity number. NIH publishes success rates by institute and activity code — source.
Portfolio context — this listing covers more than this opportunity
This opportunity is funded under Assistance Listing 93.865 (“Child Health and Human Development Extramural Research”), a broad federal program that made about 770 new awards per year over the last five fiscal years (median award $448k). Those figures describe that whole portfolio — not this specific solicitation, so we don't show them as if they were this opportunity's track record.
Applicant counts per solicitation are not published by any federal agency — no one can honestly sell you that number. NIH publishes success rates by institute and activity code — source.
Don't want to hunt for grants like this one? Get free deadline alerts for your state and focus areas.
Consultant or grant writer? See the client-ready Opportunity Brief for this grant — actual award sizes vs. the advertised ceiling, who wins, printable "prepared for your client" version.
Similar grants still open
| Opportunity | Agency | Deadline | Award ceiling | Eligible |
|---|---|---|---|---|
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) | National Institutes of Health | November 23, 2026 | $375k | |
| BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional) | National Institutes of Health | June 15, 2027 | — | Nonprofits |
| Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed) | National Institutes of Health | September 7, 2027 | — | Nonprofits |
| Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed) | National Institutes of Health | September 7, 2027 | — | Nonprofits |